EUVIMEDEUVIMED entdecken
FallberichtOpen Access

A child with TSC2/PKD1 contiguous gene deletion syndrome successfully treated with tolvaptan for rapidly enlarging renal cysts

Chika Muroga, Hiroki Yokoyama iD, Ryo Kinoshita, Daisuke Fujimori, Yuko Yamada, Tohru Okanishi, Naoya Morisada, Kandai Nozu, Noriyuki Namba

CEN Case Reports · 2024

DOI: 10.1007/s13730-024-00854-6 ↗

Kurz gefasst

Fallbericht in der Zeitschrift CEN Case Reports, 2024. Verfasst von Chika Muroga und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatrics and Perinatology, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago, Tottori, 683-8504, Japan. Hauptthemen laut MEDLINE: Tolvaptan, Tuberous Sclerosis Complex 2 Protein, TRPP Cation Channels, Antidiuretic Hormone Receptor Antagonists. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tolvaptan, a vasopressin receptor antagonist, has been shown to be effective in the treatment of renal cysts in ADPKD. However, tolvaptan is not indicated for pediatric patients, and reports of its use are rare, making its efficacy and adverse reactions unclear. Herein, we present the case of an 11-year-old girl who had vitiligo from birth. She was diagnosed with West syndrome at 6 months of age and tuberous sclerosis at 2 years of age. At the age of 6 years, an abdominal magnetic resonance imaging (MRI) revealed multiple bilateral renal cysts, and she was diagnosed with ADPKD. Abdominal MRI scans performed at 10 years and 11 years showed rapid renal cyst enlargement, and the renal prognosis was judged to be poor. The patient was treated with tolvaptan to delay cyst exacerbation. There were no apparent adverse events after the initiation of treatment, and the MRI performed 12 months after treatment initiation showed that renal cyst enlargement was suppressed. The results suggest that tolvaptan may be effective in pediatric patients with severe ADPKD who have rapidly enlarging renal cysts, although evaluation of renal cyst enlargement and side effects should be continued.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TolvaptanTuberous Sclerosis Complex 2 ProteinTRPP Cation ChannelsAntidiuretic Hormone Receptor AntagonistsTuberous SclerosisMagnetic Resonance ImagingPolycystic Kidney, Autosomal DominantHumansFemaleChildGene DeletionTreatment Outcome

Stichwörter der Autor:innen

Gene deletionKidney neoplasmTolvaptan

Substanzen

TolvaptanTuberous Sclerosis Complex 2 ProteinTRPP Cation ChannelsAntidiuretic Hormone Receptor AntagonistsTSC2 protein, human

Autor:innen und Institutionen

  • Division of Pediatrics and Perinatology, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago, Tottori, 683-8504, Japan.
  • Division of Pediatrics and Perinatology, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago, Tottori, 683-8504, Japan. hirokiy1+med@gmail.com.
  • Division of Child Neurology, Faculty of Medicine, Institute of Neurological Sciences, Tottori University, Yonago, Japan.
  • Department of Clinical Genetics, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
  • Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.

ORCID-Profile: Hiroki Yokoyama

Zitieren

APA

Muroga, C., Yokoyama, H., Kinoshita, R., Fujimori, D., Yamada, Y., Okanishi, T., Morisada, N., Nozu, K., & Namba, N. (2024). A child with TSC2/PKD1 contiguous gene deletion syndrome successfully treated with tolvaptan for rapidly enlarging renal cysts. CEN Case Reports. https://doi.org/10.1007/s13730-024-00854-6

Vancouver

Muroga C, Yokoyama H, Kinoshita R, Fujimori D, Yamada Y, Okanishi T, et al. A child with TSC2/PKD1 contiguous gene deletion syndrome successfully treated with tolvaptan for rapidly enlarging renal cysts. CEN Case Reports. 2024. doi:10.1007/s13730-024-00854-6

BibTeX
@article{Muroga2024,
  author = {Muroga, Chika and Yokoyama, Hiroki and Kinoshita, Ryo and Fujimori, Daisuke and Yamada, Yuko and Okanishi, Tohru and Morisada, Naoya and Nozu, Kandai and Namba, Noriyuki},
  title = {A child with TSC2/PKD1 contiguous gene deletion syndrome successfully treated with tolvaptan for rapidly enlarging renal cysts},
  journal = {CEN Case Reports},
  year = {2024},
  doi = {10.1007/s13730-024-00854-6}
}
Kostenlos starten →